DeepVerge has announced its new R&D service, which was launched in August 2020, has already generated £400,000 in completed sales in Q4 2020.
TPI provides its latest research note on DeepVerge plc (DVRG.L).
DeepVerge has announced breakthrough interim analysis that demonstrates its ability to host the SARS-CoV-2 virus on Labskin-cloned human skin microbiome.
TPI provides its latest research note on DeepVerge plc (DVRG.L).
As part of the extended field trial for DeepVerge’s Microtox PD unit, its COVID-19 enabled near-source wastewater contamination test system, deployment into a number ofIrish water treatment plants has now